| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 11.39 M USD | 9.07 M USD | 1.31 M USD | -686000 USD | 3.08 M USD | 4.20 M USD | 2.59 M USD | 2.44 M USD | 1.19 M USD | 2.17 M USD | 2.78 M USD | 2.06 M USD |
| Depreciation & Amortization | 1.04 M USD | 789000 USD | 550000 USD | 503000 USD | 477000 USD | 616468 USD | 804587 USD | 676426 USD | 636709 USD | 616021 USD | 613304 USD | 567341 USD |
| Stock-Based Compensation | 3.06 M USD | 1.69 M USD | 708000 USD | 976000 USD | 1.02 M USD | 901932 USD | 924071 USD | 862674 USD | 479482 USD | 222763 USD | 110350 USD | 82228 USD |
| Capital Expenditures | 262000 USD | 287000 USD | 1.65 M USD | 1.43 M USD | 287000 USD | 844226 USD | 1.33 M USD | 526227 USD | 618763 USD | 534944 USD | 523185 USD | 895177 USD |
| Cash Flow from Investing | -306000 USD | -395000 USD | -1.72 M USD | -1.52 M USD | -448000 USD | -977196 USD | -1.39 M USD | -571777 USD | -687148 USD | -579521 USD | -624507 USD | -935799 USD |
| Cash Flow from Financing | -11.88 M USD | 36000 USD | -380000 USD | -1.52 M USD | -1.22 M USD | -548030 USD | -851152 USD | 11712 USD | -53619 USD | -62267 USD | -61169 USD | -127724 USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 10.00 M USD | 275000 USD | 153000 USD | 1.45 M USD | 1.12 M USD | — | — | — | — | — | — | — |
| Free Cash Flow | 11.13 M USD | 8.78 M USD | -333000 USD | -2.11 M USD | 2.79 M USD | 3.35 M USD | 1.26 M USD | 1.92 M USD | 572358 USD | 1.63 M USD | 2.26 M USD | 1.17 M USD |
Electromed Inc. is a leading manufacturer and distributor of medical devices, primarily focusing on respiratory therapy solutions. The company is renowned for its development of innovative airway clearance products, particularly the SmartVest Airway Clearance System, which assists patients with impaired breathing due to conditions like cystic fibrosis, bronchiectasis, and neuromuscular disorders. Electromed Inc. operates mainly within the healthcare sector, providing advanced solutions that improve patient outcomes and enhance quality of life for individuals with chronic respiratory conditions. The company's commitment to research and development helps it maintain a competitive edge, ensuring its products are at the forefront of medical technology. Electromed Inc.'s significant role in the market is underscored by its focus on expanding accessibility to its medical devices, through strategic partnerships and health care provider networks, thereby reinforcing its presence and influence in the respiratory care segment.